Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-81.15M
↓ 67% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-48.50M
Historical baseline
PeriodValueYoY Change
2024$-81.15M-36.4%
2023$-59.50M-9.0%
2022$-54.56M-23.5%
2021$-44.18M-1310.0%
2020$-3.13M-